PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.\', \'State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated with the Shanghai Jiao Tong University (SJTU) School of Medicine, Shanghai, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.5582/bst.2021.01227
?:doi
?:hasPublicationType
?:journal
  • Bioscience trends
is ?:pmid of
?:pmid
?:pmid
  • 34135261
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.591
?:rankingScore_hIndex
  • 23
?:title
  • Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34135261>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34135261>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all